Fermentable carbohydrate alters hypothalamic neuronal activity and protects against the obesogenic environment

Obesity

Volumn 20, Issue 5, 2012, Pages 1016-1023

  Anastasovska, Jelena ^a   Arora, Tulika ^b   Sanchez Canon, Gina J ^a   Parkinson, James R C ^a   Touhy, Kieran ^c   R Gibson, Glen ^c   Nadkarni, Nachiket A ^a   So, Po Wah ^a,d   Goldstone, Anthony P ^a   Thomas, E Louise ^a   K Hankir, Mohammed ^a   Van Loo, Jan ^e   Modi, Neena ^a   Bell, Jimmy D ^a   Frost, Gary ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b NATIONAL DAIRY RESEARCH INSTITUTE   (India)

^c UNIVERSITY OF READING   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e BENEO Group   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

INULIN; SHORT CHAIN FATTY ACID; STARCH;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARCUATE NUCLEUS; ARTICLE; BIFIDOBACTERIUM; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG EFFECT; FAT CONTENT; FECES MICROFLORA; HYPOTHALAMUS; LACTOBACILLUS; LIPID DIET; LIVER; MALE; MOUSE; NERVE CELL; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; THERAPY EFFECT; WEIGHT GAIN; WEIGHT REDUCTION;

ANIMAL FEED; ANIMALS; APPETITE REGULATION; DIETARY CARBOHYDRATES; DIETARY SUPPLEMENTS; FERMENTATION; HYPOTHALAMUS; INULIN; MALE; MICE; MICE, INBRED C57BL; OBESITY; SIGNAL TRANSDUCTION; WEIGHT LOSS;

ANIMALIA; BACTERIA (MICROORGANISMS); MUS; ZEA MAYS;

EID: 84860297167     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2012.6     Document Type: Article

References (40)

1. Obesity: Preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000;894:i-xii, 1-253.
2. Prentice AM, Jebb SA. Fast foods, energy density and obesity: A possible mechanistic link. Obes Rev 2003;4:187-194.
3. Eaton SB. The ancestral human diet: what was it and should it be a paradigm for contemporary nutrition? Proc Nutr Soc 2006;65:1-6.
4. van Dam RM, Seidell JC. Carbohydrate intake and obesity. Eur J Clin Nutr 2007;61(Suppl 1):S75-S99.
5. Niness KR. Inulin and oligofructose: what are they? J Nutr 1999;129:1402S-1406S.
6. Letexier D, Diraison F, Beylot M. Addition of inulin to a moderately highcarbohydrate diet reduces hepatic lipogenesis and plasma triacylglycerol concentrations in humans. Am J Clin Nutr 2003;77:559-564.
7. So PW, Yu WS, Kuo YT et al. Impact of resistant starch on body fat patterning and central appetite regulation. PLoS ONE 2007;2:e1309.
8. Cani PD, Neyrinck AM, Maton N, Delzenne NM. Oligofructose promotes satiety in rats fed a high-fat diet: Involvement of glucagon-like Peptide-1.Obes Res 2005;13:1000-1007.
9. Cummings JH, Pomare EW, Branch WJ, Naylor CP, Macfarlane GT. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 1987;28:1221-1227.
10. Tarini J, Wolever TM. The fermentable fibre inulin increases postprandial serum short-chain fatty acids and reduces free-fatty acids and ghrelin in healthy subjects. Appl Physiol Nutr Metab 2010;35:9-16.
11. Song WS, Nielson BR, Banks KP, Bradley YC. Normal organ standard uptake values in carbon-11 acetate PET imaging. Nucl Med Commun 2009;30:462-465.
12. Carmichael FJ, Israel Y, Crawford M et al. Central nervous system effects of acetate: Contribution to the central effects of ethanol. J Pharmacol Exp Ther 1991;259:403-408.
13. Parkinson JR, Chaudhri OB, Bell JD. Imaging appetite-regulating pathways in the central nervous system using manganese-enhanced magnetic resonance imaging. Neuroendocrinology 2009;89:121-130.
14. Silva AC, Lee JH, Aoki I, Koretsky AP. Manganese-enhanced magnetic resonance imaging (MEMRI): Methodological and practical considerations. NMR Biomed 2004;17:532-543.
15. Parkinson JR, Chaudhri OB, Kuo YT et al. Differential patterns of neuronal activation in the brainstem and hypothalamus following peripheral injection of GLP-1, oxyntomodulin and lithium chloride in mice detected by manganese-enhanced magnetic resonance imaging (MEMRI). Neuroimage 2009;44:1022-1031.
16. Kuo YT, Herlihy AH, So PW, Bell JD. Manganese-enhanced magnetic resonance imaging (MEMRI) without compromise of the blood-brain barrier detects hypothalamic neuronal activity in vivo. NMR Biomed 2006;19:1028-1034.
17. Franks AH, Harmsen HJ, Raangs GC et al. Variations of bacterial populations in human feces measured by fluorescent in situ hybridization with group-specific 16S rRNA-targeted oligonucleotide probes. Appl Environ Microbiol 1998;64:3336-3345.
18. Salzman NH, de Jong H, Paterson Y et al. Analysis of 16S libraries of mouse gastrointestinal microflora reveals a large new group of mouse intestinal bacteria. Microbiology 2002;148:3651-3660.
19. Rycroft CE, Jones MR, Gibson GR, Rastall RA. A comparative in vitro evaluation of the fermentation properties of prebiotic oligosaccharides. J Appl Microbiol 2001;91:878-887.
20. Kreymann B, Williams G, Ghatei MA, Bloom SR. Glucagon-like peptide-17-36: A physiological incretin in man. Lancet 1987;2:1300-1304.
21. Richardson A, Delbridge AT, Brown NJ, Rumsey RDE, Read NW. Ileal infusion of short chain fatty acids accelerates stomach to cecum transit-time in the rat. Gut 1989;30: A1446.
22. Thomas EL, Saeed N, Hajnal JV et al. Magnetic resonance imaging of total body fat. J Appl Physiol 1998;85:1778-1785.
23. Mystkowski P, Shankland E, Schreyer SA et al. Validation of whole-body magnetic resonance spectroscopy as a tool to assess murine body composition. Int J Obes Relat Metab Disord 2000;24:719-724.
24. Hankir MK, Parkinson JR, Minnion JS et al. Peptide YY3-36 and pancreatic polypeptide differentially regulate hypothalamic neuronal activity in mice In Vivo as measured by manganese-enhanced magnetic resonance imaging. J Neuroendocrinol 2011;23:371-380.
25. Franklin KBJ, Paxinos G. The Mouse Brain in Stereotaxic Coordinates. Academic Press: San Diego, CA, 1997.
26. Daubioul C, Rousseau N, Demeure R et al. Dietary fructans, but not cellulose, decrease triglyceride accumulation in the liver of obese Zucker fa/fa rats. J Nutr 2002;132:967-973.
27. Cani PD, Lecourt E, Dewulf EM et al. Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal. Am J Clin Nutr 2009;90:1236-1243.
28. Jamieson JA, Ryz NR, Taylor CG, Weiler HA. Dietary long-chain inulin reduces abdominal fat but has no effect on bone density in growing female rats. Br J Nutr 2008;100:451-459.
29. Daubioul CA, Taper HS, De Wispelaere LD, Delzenne NM. Dietary oligofructose lessens hepatic steatosis, but does not prevent hypertriglyceridemia in obese zucker rats. J Nutr 2000;130:1314-1319.
30. Kok N, Roberfroid M, Delzenne N. Dietary oligofructose modifies the impact of fructose on hepatic triacylglycerol metabolism. Metab Clin Exp 1996;45:1547-1550.
31. Waldram A, Holmes E, Wang Y et al. Top-down systems biology modeling of host metabotype-microbiome associations in obese rodents. J Proteome Res 2009;8:2361-2375.
32. Cani PD, Neyrinck AM, Fava F et al. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 2007;50:2374-2383.
33. Zhou J, Martin RJ, Tulley RT et al. Failure to ferment dietary resistant starch in specific mouse models of obesity results in no body fat loss. J Agric Food Chem 2009;57:8844-8851.
34. Cani PD, Hoste S, Guiot Y, Delzenne NM. Dietary non-digestible carbohydrates promote L-cell differentiation in the proximal colon of rats. Br J Nutr 2007;98:32-37.
35. Uribe A, Alam M, Johansson O, Midtvedt T, Theodorsson E. Microflora modulates endocrine cells in the gastrointestinal mucosa of the rat. Gastroenterology 1994;107:1259-1269.
36. Zhou J, Martin RJ, Tulley RT et al. Dietary resistant starch upregulates total GLP-1 and PYY in a sustained day-long manner through fermentation in rodents. Am J Physiol Endocrinol Metab 2008;295:E1160-E1166.
37. Zheng H, Lenard NR, Shin AC, Berthoud HR. Appetite control and energy balance regulation in the modern world: Reward-driven brain overrides repletion signals. Int J Obes (Lond) 2009;33 Suppl 2:S8-13.
38. Halford JC, Boyland EJ, Blundell JE, Kirkham TC, Harrold JA. Pharmacological management of appetite expression in obesity. Nat Rev Endocrinol 2010;6:255-269.
39. Brown AJ, Goldsworthy SM, Barnes AA et al. The Orphan G proteincoupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J Biol Chem 2003;278:11312-11319.
40. Vogt JA, Wolever TM. Fecal acetate is inversely related to acetate absorption from the human rectum and distal colon. J Nutr 2003;133:3145-3148.